Sustained release formulations of sotalol
    1.
    发明申请
    Sustained release formulations of sotalol 有权
    索他洛尔缓释制剂

    公开(公告)号:US20090047346A1

    公开(公告)日:2009-02-19

    申请号:US12231896

    申请日:2008-09-05

    申请人: Bramah N. Singh

    发明人: Bramah N. Singh

    IPC分类号: A61K31/18 A61K9/22 A61P9/00

    摘要: Sustained release compositions of sotalol, or a pharmaceutically acceptable salt thereof, are provided. In certain examples, sotalol, or a pharmaceutically acceptable salt thereof, may be administered in an effective amount to provide a therapeutic effect to a patient, such as, for example, a patient suffering from a cardiac disorder. In some examples, sotalol combined with a sustained release system may be administered to provide a sustained release of sotalol for a desired period, e.g., at least about 24 hours.

    摘要翻译: 提供索他洛尔或其药学上可接受的盐的缓释组合物。 在某些实例中,索他洛尔或其药学上可接受的盐可以以有效的量施用,以向患者(例如患有心脏病症的患者)提供治疗效果。 在一些实例中,可以施用与持续释放系统结合的索他洛糖,以提供持续释放索他洛尔所需的时间,例如至少约24小时。

    Sustained release formulations of sotalol

    公开(公告)号:US09616026B2

    公开(公告)日:2017-04-11

    申请号:US12231896

    申请日:2008-09-05

    申请人: Bramah N. Singh

    发明人: Bramah N. Singh

    IPC分类号: A61K9/20 A61K9/00 A61K47/36

    摘要: Sustained release compositions of sotalol, or a pharmaceutically acceptable salt thereof, are provided. In certain examples, sotalol, or a pharmaceutically acceptable salt thereof, may be administered in an effective amount to provide a therapeutic effect to a patient, such as, for example, a patient suffering from a cardiac disorder. In some examples, sotalol combined with a sustained release system may be administered to provide a sustained release of sotalol for a desired period, e.g., at least about 24 hours.